In this review, we described many pieces of evidence that make it clear that TGF-β signalling is the target of vascular fibrosis, IPF, cardiac fibrosis, liver fibrosis, and renal fibrosis. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.